Press & Media
-
PivotalPath Creates COVID-19 Analysis Tool
We created a COVID-19 data-monitoring tool where our clients and fellow citizens can reference trusted data and stay informed.
-
Capacity Crunch Limits Tech, Healthcare Specialty Investing
CEO Jon Caplis spent time with Pensions & Investments to describe the strength of TMT and healthcare hedge fund returns, and alpha generated over the long-run.
-
Some Good News For Hedge Funds
Why are institutional investors actively considering additional hedge fund investments in 2020?
-
2020 Hedge Fund Outlook
CEO Jon Caplis talked about the state of the hedge fund industry live on TD Ameritrade Network.
-
Hedge Funds Are Flocking to Miami This Week in Search of New Money
When you dig into the data, it isn't surprising that the quality of current launches is attracting attention from institutional allocators.
-
Things May Be Looking Up for Hedge Funds
Are things looking up for hedge funds? As it turns out, 2019 was a better year than many may realize.
-
Managers Eye More Return Dispersion
CEO Jon Caplis weighs in on the positive implications of rising dispersion for hedge fund performance in 2020.
-
Hedge Closures Mount in Rough 2019
PivotalPath’s research tells a different story than the headline suggests.
-
It May Finally Be Hedge Funds’ Time to Shine
What happens when global macro stops looking like healthcare?
-
Ex-Citadel, Highland Managers Start Hedge Fund With $750 Million
PivotalPath’s Head of Research, Mark Doherty, talks hedge fund healthcare investing with Bloomberg’s Katia Porzecanski.
